top of page
Supported projects
VIOLET Pharmaceuticals
A first-in-class LCOR (Ligand-dependent corepressor) mRNA therapy designed to enhance the efficacy of cancer immunotherapies in metastatic settings.
PSCC's entrance
December 2025
Localization
ES - Espagne
Modality
Immunotherapy
Development status
Biotech - Lead optimization
Award(s)
bottom of page